Novel use of XSTAT 30 for mitigation of lethal non-compressible torso hemorrhage in swine
Background Management of Non-Compressible Torso Hemorrhage (NCTH) consists primarily of aortic occlusion which has significant adverse outcomes, including ischemia-reperfusion injury, in prolonged field care paradigms. One promising avenue for treatment is through use of RevMedx XSTAT 30™ (an FDA ap...
Main Authors: | Alicia M. Bonanno, Todd L. Graham, Lauren N. Wilson, James D. Ross, Erin Lavik |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673511/?tool=EBI |
Similar Items
-
Novel use of XSTAT 30 for mitigation of lethal non-compressible torso hemorrhage in swine.
by: Alicia M Bonanno, et al.
Published: (2020-01-01) -
Management of non-compressible torso hemorrhage: An update
by: Zhi-Yang Zhang, et al.
Published: (2021-05-01) -
A novel tamponade agent for management of post partum hemorrhage: adaptation of the Xstat mini-sponge applicator for obstetric use
by: Maria I. Rodriguez, et al.
Published: (2017-06-01) -
Torso as ceramic vessel
by: Masterson, Richard Garrett
Published: (1990) -
A meta-analysis of resuscitative endovascular balloon occlusion of the aorta (REBOA) or open aortic cross-clamping by resuscitative thoracotomy in non-compressible torso hemorrhage patients
by: Ramiro Manzano Nunez, et al.
Published: (2017-07-01)